Coverage
-
March 28, 2016
A Florida federal judge on Monday barred Actavis from launching its generic version of Shire’s inflammatory bowel disease treatment Lialda until the patent for the drug expires in June 2020, following a second bench trial on the matter.
4 other articles on this case.
View all »